U.S. drug overdose deaths fell for a third consecutive year in 2025, with deaths involving synthetic opioids such as illicit fentanyl declining by 22%, according to provisional data from the Centers for Disease Control and Prevention (CDC).
The CDC estimates that 69,973 people died from drug overdoses in the United States in 2025, down from 81,313 deaths in 2024. That represents a decline of nearly 14%.
Deaths involving synthetic opioids, a category that includes fentanyl, fell from an estimated 48,913 in 2024 to 38,084 in 2025—a reduction of 10,829 deaths, or about 22%.
The decline comes as the United States marks National Fentanyl Prevention and Awareness Day on August 21, a day focused on the dangers of illicit fentanyl, counterfeit pills and fentanyl poisoning.
U.S. Overdose Deaths Fell Nearly 14% in 2025
The latest CDC figures show that the decline was broader than fentanyl alone.
| Drug category | 2024 estimated deaths | 2025 estimated deaths | Change |
|---|---|---|---|
| Total drug overdoses | 81,313 | 69,973 | −14% |
| Synthetic opioids, including fentanyl | 48,913 | 38,084 | −22% |
| Opioids overall | 55,296 | 44,564 | −19% |
| Psychostimulants, including methamphetamine | 29,852 | 26,181 | −12% |
| Cocaine | 22,397 | 19,581 | −13% |
| Natural and semisynthetic opioids | 8,082 | 7,065 | −13% |
The figures are provisional, meaning they can change as additional death records are submitted and processed. Drug categories can also overlap because a single overdose death may involve multiple substances.
That distinction matters when interpreting the numbers. The 38,084 figure should not be treated as a count of deaths caused exclusively by fentanyl because the CDC’s synthetic-opioid category covers more than one substance.
Most States Saw Overdose Deaths Decline
The national improvement was widespread, although it was not uniform across the country.
According to the CDC, Rhode Island, New York, North Carolina, Alabama and Vermont each recorded declines of at least 25% in overdose deaths compared with the previous year.
At the other end of the spectrum, New Mexico, Arizona and Colorado recorded increases of at least 10%.
The state-level differences show why the national decline does not mean the fentanyl crisis has ended. Some communities continue to face significant risks from fentanyl, counterfeit pills and combinations of synthetic drugs.
Why Are Overdose Deaths Falling?
The decline does not appear to have one universally established explanation.
Public-health efforts, treatment access, naloxone availability, changes in the illicit drug supply and prevention programs have all been part of the broader response to the overdose crisis. The CDC continues to track access to naloxone and medications for opioid use disorder as important components of overdose prevention.
At the same time, law enforcement agencies point to changes in the illegal fentanyl market and enforcement against trafficking networks.
Because the 2025 CDC figures are population-level mortality data, however, they cannot by themselves determine how much of the decline came from any individual federal policy, enforcement operation or public-health program.
That is particularly important when assessing claims made by the Trump administration.
White House Credits Trump Administration’s Fentanyl Crackdown
The White House has pointed to the decline as evidence that its policies targeting fentanyl trafficking are having an effect.
In a July 2026 release, the White House highlighted the 22% decline in synthetic-opioid deaths and the nearly 14% decline in total overdose deaths. It attributed the progress to a broader strategy involving border security, action against drug-trafficking organizations and pressure on foreign suppliers.
The administration has also highlighted legislation and enforcement measures aimed at fentanyl trafficking and the organizations involved in the illicit supply chain.
However, the CDC’s mortality release does not conclude that the decline was caused by the Trump administration’s policies. The 2025 data cover the full calendar year, while the administration began on January 20, 2025, and the national decline was already underway before then.
That makes it more accurate to say that the overdose decline occurred during 2025 and that the White House credits its policies for helping accelerate or sustain the trend, rather than saying the CDC proved those policies caused the decline.
DEA Has Seized Millions of Fentanyl Pills in 2026
Law enforcement activity remains a major part of the federal response.
The DEA reported that, as of August 3, 2026, it had seized more than 20.3 million fentanyl pills and about 8,771 pounds of fentanyl powder during 2026. The agency said those seizures represented more than 210 million potentially deadly doses based on its estimate that 2 milligrams of fentanyl can constitute a potentially lethal dose.
For comparison, the DEA said it seized more than 47 million fentanyl-laced counterfeit pills and nearly 10,000 pounds of fentanyl powder in 2025.
These seizure figures demonstrate the scale of the illegal fentanyl market and federal enforcement activity, but they should not be interpreted on their own as proof that enforcement caused the decline in overdose deaths.
Fentanyl Remains a Serious Threat
Despite the decline in deaths, federal health and law enforcement agencies continue to warn that fentanyl remains highly dangerous.
The DEA says fentanyl is approximately 50 times more potent than heroin and 100 times more potent than morphine. Illicit fentanyl can also appear in counterfeit pills designed to resemble legitimate prescription medications.
DEA laboratory testing reported in 2026 found that 29% of fentanyl pills analyzed during fiscal year 2025 contained a potentially lethal dose, compared with 76% of pills tested in fiscal year 2023. The agency also reported that fentanyl powder purity fell during the same period.
The presence of fentanyl in counterfeit pills remains particularly concerning because people may not know what substance they are taking.
The DEA has also warned that illicit fentanyl is increasingly being found alongside other emerging synthetic substances, including nitazenes, xylazine and medetomidine, making the illegal drug supply more unpredictable.
The Decline Is Significant, but the Crisis Is Not Over
The 2025 numbers represent a major improvement from the peak years of the U.S. overdose crisis.
Still, nearly 70,000 Americans died from drug overdoses in a single year. The continuing increases in some states also show that progress has not reached every community equally.
The CDC’s data therefore provide two messages at once: the national trend is moving in a positive direction, but the underlying overdose crisis remains substantial.
National Fentanyl Prevention and Awareness Day also serves as a reminder that declining mortality does not eliminate the need for prevention, treatment, recovery services and efforts to reduce exposure to illicit fentanyl.
What the 2025 Data Shows
The latest figures establish several clear trends:
- U.S. drug overdose deaths declined for the third consecutive year.
- Total overdose deaths fell nearly 14%, from 81,313 to 69,973.
- Deaths involving synthetic opioids fell about 22%, from 48,913 to 38,084.
- Opioid-involved overdose deaths fell from 55,296 to 44,564.
- Most states recorded declines, but New Mexico, Arizona and Colorado saw increases of at least 10%.
- The CDC data are provisional and may be revised.
- The White House credits its fentanyl and trafficking policies for the decline, but the CDC data do not establish a single cause.
- DEA enforcement data show that millions of fentanyl pills and thousands of pounds of fentanyl powder have continued to be seized in 2026.
The Bottom Line
The United States made substantial progress against fatal drug overdoses in 2025, particularly with the sharp decline in deaths involving synthetic opioids such as fentanyl. But with nearly 70,000 overdose deaths still estimated for the year and some states moving in the opposite direction, the latest figures show significant progress—not the end of the fentanyl crisis.
